By proceeding, you agree to our Terms of Use and Privacy Policy.
2023 is set to be a landmark year for lipid-based delivery technology development and the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit returns to unite 140+ biopharma thought leaders in the field all racing to uncover the potential of lipid-delivery properties.This is your definitive industry-led meeting to discover new lipid-based nanoparticle formulations and engineer delivery systems for emerging payloads beyond RNA for extrahepatic delivery.Providing a complete picture of the lipid-based delivery landscape, from liposomes to LNPs, polymeric lipid nanoparticles, lipid nano-crystals and beyond, join market-leaders to progress your candidates to the clinic applying translatability insights to safeguard payload safety and efficacy.
Uncover the potential of novel lipid vehicles for extrahepatic delivery.
Advance your knowledge of the lipid-based delivery landscape, from liposomes to LNPs, polymeric lipid nanoparticles, lipid nano-crystals and beyond.
Join the interactive sessions to progress your candidates to the clinic, applying translatability insights to safeguard payload safety and efficacy.
Draw inspiration from the insights of industry influencers to expedite the next generation of lipid-based nanoparticle delivery systems closer to the patient.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Lipoid as the world's leading cGMP manufacturer of purified lecithins and phospholipids for pharmaceutical use. Lipoid produces natural purified lecithins and phospholipids derived from soy and egg.
Visualizing biomolecular structures through cryo-EM studies can provide insight into multiple stages of the drug development process, from target identification through formulation and manufacturing.
The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism- driven quantum mechanics and molecular dynamics simulations to calculate Active Pharmaceutical Ingredient (API) properties, elucidate API-target and API-excipi
The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism- driven quantum mechanics and molecular dynamics simulations to calculate Active Pharmaceutical Ingredient (API) properties, elucidate API-target and API-excipient interactions, and predict chemical, physical a
Curapath is a CDMO with expertise in developing novel drug delivery systems (DDS). What sets us apart is our analytical expertise in the formulation and manufacturing of Lipid nanoparticles (LNP) and Polymer nanoparticles (PNP). When you start workin
Curapath is a CDMO with expertise in developing novel drug delivery systems (DDS). What sets us apart is our analytical expertise in the formulation and manufacturing of Lipid nanoparticles (LNP) and Polymer nanoparticles (PNP). When you start working with Curapath, we can support your entire therap
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.